Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NO-1886 in phase II clinical trials

June 7, 1996

Sankyo discovers ACAT inhibitor

June 7, 1996

Hoescht reports imidobisphosphonic acid derivatives

June 7, 1996

Fujisawa claims ACAT inhibitors

June 7, 1996

Completion of phase I clinical trials on human red blood cell substitute

May 31, 1996

Celtrix announces the initiation of two phase I trials of SomatoKine

May 31, 1996

ACAT inhibitors from Warner-Lambert

May 31, 1996

Multicenter clinical trial indicates alendronate effective in osteoporotic fracture prevention

May 31, 1996

PKC pathway activation may have therapeutic significance in bone disease management

May 31, 1996

New contraceptives reported by Akzo Nobel

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...